MRPI

Mera Pharmaceuticals, Inc. MRPI

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode MRPI LADX NNBP DNAG USRM MLPH MHTX HENC BIOIF CBGL
6M 0.00 % -92.00 % 0.00 % 0.00 % -50.00 % 300.00 % 0.00 % 0.00 % 0.00 % 180.00 %
YTD 0.00 % -93.91 % 0.00 % 900.00 % 0.00 % 300.00 % -88.89 % 0.00 % -92.19 % -6.67 %
1Y 0.00 % -93.48 % 9 900.00 % 900.00 % 0.00 % 300.00 % -87.50 % 0.00 % -86.84 % 40.00 %
3Y 0.00 % -99.30 % 0.00 % 900.00 % -97.92 % 300.00 % -99.00 % -99.69 % -93.54 % -65.00 %
5Y -99.20 % -99.89 % -80.00 % -99.00 % -98.63 % -73.33 % -99.75 % -99.82 % -98.33 % -99.90 %
10Y -50.00 % -99.99 % 0.00 % -99.00 % -99.99 % -93.33 % -99.85 % -99.88 % -99.52 % -99.53 %
From the beginning -99.90 % -100.00 % -100.00 % -100.00 % -100.00 % -96.80 % -100.00 % -99.99 % -99.67 % -90.67 %

Dividend

LadRx Corporation